Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050

Published: June 04, 2024

population level economic burden of key cardiovascular risk factors in US adults 2020 to 2050
  • High prevalence of cardiovascular disease (CVD) in the United States (US) remains an important driver of health care costs, accounting for billions of dollars in health care spending.
  • It is crucial to quantify the economic burden of CVD over the coming decades as these forecasted data can help inform policy, and health system and community-level interventions for CVD prevention and treatment.
  • This scientific statement projects health care and societal costs of key cardiovascular risk factors and CVD in U.S. adults through 2050, and includes an expanded scope, more risk factors and different demographic and socioeconomic factors compared to prior AHA statements on economic burden of CVD.